全文获取类型
收费全文 | 3150篇 |
免费 | 165篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 94篇 |
妇产科学 | 80篇 |
基础医学 | 527篇 |
口腔科学 | 38篇 |
临床医学 | 238篇 |
内科学 | 833篇 |
皮肤病学 | 41篇 |
神经病学 | 407篇 |
特种医学 | 88篇 |
外科学 | 237篇 |
综合类 | 9篇 |
预防医学 | 161篇 |
眼科学 | 33篇 |
药学 | 215篇 |
中国医学 | 10篇 |
肿瘤学 | 313篇 |
出版年
2024年 | 8篇 |
2023年 | 29篇 |
2022年 | 56篇 |
2021年 | 98篇 |
2020年 | 54篇 |
2019年 | 61篇 |
2018年 | 106篇 |
2017年 | 79篇 |
2016年 | 72篇 |
2015年 | 100篇 |
2014年 | 117篇 |
2013年 | 168篇 |
2012年 | 244篇 |
2011年 | 235篇 |
2010年 | 131篇 |
2009年 | 140篇 |
2008年 | 238篇 |
2007年 | 226篇 |
2006年 | 210篇 |
2005年 | 190篇 |
2004年 | 207篇 |
2003年 | 152篇 |
2002年 | 145篇 |
2001年 | 30篇 |
2000年 | 17篇 |
1999年 | 28篇 |
1998年 | 34篇 |
1997年 | 32篇 |
1996年 | 24篇 |
1995年 | 10篇 |
1994年 | 19篇 |
1993年 | 16篇 |
1992年 | 16篇 |
1991年 | 5篇 |
1990年 | 4篇 |
1989年 | 5篇 |
1988年 | 7篇 |
1987年 | 7篇 |
1986年 | 6篇 |
1985年 | 4篇 |
1984年 | 4篇 |
1983年 | 4篇 |
1982年 | 1篇 |
1980年 | 1篇 |
1977年 | 1篇 |
1975年 | 1篇 |
排序方式: 共有3342条查询结果,搜索用时 31 毫秒
51.
Maria Raffaella Ambrosio Bruno Jim Rocca Maria Grazia Mastrogiulio Alia Lutfi Stefano Lazzi Sergio Antonio Tripodi 《Esophagus》2014,11(2):136-139
Acute esophageal necrosis, commonly referred to as ‘black esophagus?, is a rare clinical entity arising from a combination of ischemic insult, corrosive injury and decreased function of mucosal barrier systems and reparative mechanisms present in debilitating diseases. We describe the case of an 18-year-old man affected by Down syndrome, presenting with a streptococcus β-hemolytic group A infection of the upper airways. Although the patient was intensively treated with antibiotics, he developed a streptococcal toxic shock-like syndrome and died 5 days after admission. At autopsy, circumferential black discoloration of the esophageal mucosa that extended along the entire esophagus and ended abruptly at the esophageal-gastric junction was found. Neither ulceration nor esophageal perforation were present. Black esophagus is well known to the gastroenterology community, whereas it has been described only twice in the pathology literature. To the best of our knowledge, this is the first case ever reported complicating a streptococcal infection. 相似文献
52.
53.
54.
55.
56.
57.
58.
Libani IV Guy EC Melchiori L Schiro R Ramos P Breda L Scholzen T Chadburn A Liu Y Kernbach M Baron-Lühr B Porotto M de Sousa M Rachmilewitz EA Hood JD Cappellini MD Giardina PJ Grady RW Gerdes J Rivella S 《Blood》2008,112(3):875-885
In β-thalassemia, the mechanism driving ineffective erythropoiesis (IE) is insufficiently understood. We analyzed mice affected by β-thalassemia and observed, unexpectedly, a relatively small increase in apoptosis of their erythroid cells compared with healthy mice. Therefore, we sought to determine whether IE could also be characterized by limited erythroid cell differentiation. In thalassemic mice, we observed that a greater than normal percentage of erythroid cells was in S-phase, exhibiting an erythroblast-like morphology. Thalassemic cells were associated with expression of cell cycle–promoting genes such as EpoR, Jak2, Cyclin-A, Cdk2, and Ki-67 and the antiapoptotic protein Bcl-XL. The cells also differentiated less than normal erythroid ones in vitro. To investigate whether Jak2 could be responsible for the limited cell differentiation, we administered a Jak2 inhibitor, TG101209, to healthy and thalassemic mice. Exposure to TG101209 dramatically decreased the spleen size but also affected anemia. Although our data do not exclude a role for apoptosis in IE, we propose that expansion of the erythroid pool followed by limited cell differentiation exacerbates IE in thalassemia. In addition, these results suggest that use of Jak2 inhibitors has the potential to profoundly change the management of this disorder. 相似文献
59.
Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis. 总被引:18,自引:0,他引:18
Mario Angelico Daniele Di Paolo Massimo O Trinito Alessandra Petrolati Antonio Araco Settimio Zazza Raffaella Lionetti Carlo U Casciani Giuseppe Tisone 《Hepatology (Baltimore, Md.)》2002,35(1):176-181
Long-term immunoprophylaxis with anti-HBs immunoglobulins (HBIg) is used to prevent hepatitis B (HBV) reinfection after liver transplantation for HBV-related cirrhosis. This approach is highly expensive. A recent report proposed posttransplant HBV vaccination with a reinforced schedule as an alternative strategy to allow HBIg discontinuation. We investigated the efficacy of a reinforced triple course of HBV vaccination in 17 patients transplanted for HBsAg-positive cirrhosis 2 to 7 years earlier. The first cycle consisted of 3 double intramuscular doses (40 microg) of recombinant vaccine at month 0, 1, and 2, respectively. This was followed, in nonresponders, by a second cycle of 6 intradermal 10 microg doses every 15 days. All nonresponders then received a third cycle identical to the first one. Vaccination started 4.5 months after HBIg discontinuation, and lamivudine (100 mg/day) was given throughout the study. All patients were seronegative for HBsAg and HBV-DNA (by PCR) and positive for anti-HBe, and 7 were positive for anti-HDV. After the first cycle one patient (#5, 53 years old, male) developed an anti-HBs titer of 154 IU/L, another (#12) reached a titer of 20 IU/L and the remainder had titers <10 IU/L. At month 7, patient #5 reached a titer of 687 IU/L. After the second cycle only one additional patient (#9) had a slight response (an anti-HBs titer of 37 IU/L). After the third cycle patient #9 rose to an anti-HBs titer of 280 IU/L, patient #12 dropped to 10 IU/L, and no other patient responded. In conclusion, a highly reinforced HBV vaccination program is effective only in a few patients who had liver transplants for HBV-related cirrhosis. 相似文献